Ernexa Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $12.6M | $16.7M | $5.7M |
| FY2017 | $11.0M | $16.6M | $3.4M |
| FY2018 | $7.9M | $14.9M | $2.5M |
| FY2019 | $9.0M | $14.1M | $3.2M |
| FY2020 | $5.2M | $12.9M | $777.0K |
| FY2021 | $6.0M | $31.5M | $17.0M |
| FY2022 | $10.2M | $22.3M | $11.4M |
| FY2023 | $46.9M | $49.1M | $7.6M |
| FY2024 | $3.6M | $5.3M | $1.7M |
| FY2025 | $3.4M | $5.8M | $1.9M |